Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Johnson and Johnson
Medtronic
Baxter
Boehringer Ingelheim

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Litigation Details for Merck & Co., Inc. v. Mediplan Health Consulting, Inc. (S.D.N.Y. 2005)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Merck & Co., Inc. v. Mediplan Health Consulting, Inc. (S.D.N.Y. 2005)

Docket   Start Trial Date Filed 2005-04-08
Court District Court, S.D. New York Date Terminated 2007-01-23
Cause 28:1331 Fed. Question: Other Assigned To Denny Chin
Jury Demand Defendant Referred To Magistrate Judge Gabriel W. Go
Parties MEDIPLAN HEALTH CONSULTING, INC.; MERCK & CO., INC.; MSD TECHNOLOGY L.P.
Patents 4,231,938
Attorneys Ilaria Maggioni; John DeQ. Briggs; Kenneth Wade Donnelly; Nina Shreve; Peter DeForest Shapiro
Firms Fitzpatrick, Cella, Harper & Scinto; Fitzpatrick, Cella, Harper & Scinto(NYC); Howrey LLP; Howrey LLP (DC)
Link to Docket External link to docket
Small Molecule Drugs cited in Merck & Co., Inc. v. Mediplan Health Consulting, Inc.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Merck & Co., Inc. v. Mediplan Health Consulting, Inc. (S.D.N.Y. 2005)

Date Filed Document No. Description Snippet Link To Document
2005-04-08 1 a.l. . 4,137,3?.2, l/ 1979 Endo et al. ..... 4,231,938 ll/ 1980 Monaghan et al. . ........ 549/292 4,…recently, Monagl_ian et al in U.S. Pat. No.' 4,231,938, which is incorporated herein..by reference, reported…) infringement of United States Patent No. 4,444,784 (“the ‘784 patent”) under 35 U.S.C. § 271; (b) unfair….S.C. §§ 1391(d) and 1400. Merck’s Patent ll. The ‘784 patent, entitled "Antihypercholesterolemic… by the ‘784 patent and has continued to willfully and deliberately infringe that patent 25. The actions External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
McKesson
McKinsey
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.